Implantable Cartioverter Defibrillator | featured news

Charges Weigh On Medtronic's Net

Medtronic's profit dropped 69% on patent-litigation and acquisition-related charges as the medical-device maker saw sales of its implantable cartioverter defibrillators fall.

 

Subscribe to this RSS topic: Syndicate content